References
- Livermore DM, Tulkens PM. Temocillin revived. J Antimicrob Chemother. 2009;63(2):243–5.
- Pulcini C, Bush K, Craig WA, Frimodt-Møller N, Grayson ML, Mouton JW, et al. Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis. 2012;54(2):268–74.
- Rodriguez-Villalobos H, Cardentey-Reyes A, Thiroux C, Nonhoff C, Struelens MJ. Comparison of four commercial methods for determining temocillin susceptibility of Escherichia coli. J Antimicrob Chemother. 2009;63(4):832–4.
- Patel TA, Dilley R, Williams A, Vanstone GL, Balakrishnan I. Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae. J Antimicrob Chemother. 2013;68(7):1685–6.
- Vanstone GL, Dilley R, Schwenk S, Williams A, Balakrishnan I. Temocillin disc diffusion susceptibility testing by EUCAST methodology. J Antimicrob Chemother. 2013;68(11):2688–9.
- BioMérieux A. AB bioMérieux Etest® temocillin. Antimicrobial susceptibility testing for in vitro diagnostic use. Marcy l’Etoile: BioMérieux A; 2011.
- Paeme G. Bepaling van de in-vitro gevoeligheid voor temocilline. Bacteriology Newsletter. Philadelphia, PA: Smithkline Beecham Pharmaceuticals; 1998.
- Clinical and Laboratory Standards Institute. Development of in vitro susceptibility testing criteria and control parameters. Approved guideline — 3rd ed. CLSI document M23-A3. Wayne, PA: CLSI; 2008.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility test. 10th ed. CLSI approved standard M02-A10. Wayne, PA: CLSI; 2009.